Davide Bernareggi

Statistics

Publications

Citations

503

H-Index

Active since

2014

Affiliations

University of California San Diego(Current)

Oslo University Hospital

Davide Bernareggi is an author at University of California San Diego specializing in natural killer cell biology, oncology, and natural killer cell regulation.

Publications per year

2014–2022

Publications

Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity

Zhu Huang, Robert Blum, Davide Bernareggi et al. · Cell stem cell · 2020 · 334 citations · Full text

Medicine, Cancer Biology, Oncology +16

CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity

Davide Bernareggi, Qi Xie, Briana C. Prager et al. · Nature Communications · 2022 · 71 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles

Benjamin Goldenson, Zhu Huang, YunZu Michele Wang et al. · Frontiers in Immunology · 2020 · 66 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo

Alessandra Quarta, Davide Bernareggi, Fabio Benigni et al. · Nanoscale · 2014 · 32 citations

Pharmacy, Oncology, Pharmaceutics +17

1–4 of 4